BEIJING -- China will lengthen patent protection on pharmaceuticals to up to 25 years from 20 starting this month, in a move that appears aimed at deflecting U.S. criticism over intellectual property violations.
Beijing has also scrapped import tariffs ranging up to 6% on 28 categories of drugs, including those used to treat cancer.
By continuing to browse this website, you accept cookies which are used for several reasons such as personalizing content/ads and analyzing how this website is used. Please review our
to learn how you can update your cookie settings.